Used in the synthesis of pharmaceutical intermediates, particularly in the development of kinase inhibitors for cancer treatment. Shows potential as a building block in medicinal chemistry due to its fluorinated cyclopropyl-oxazepinone structure, which enhances binding selectivity and metabolic stability in drug candidates. Employed in research settings to design compounds targeting neurological disorders and inflammatory diseases.